aod9604 half life pharmacokinetics Terminal half-life and the time required to reach steady-state The application of half-life in

(2021) This placebo-controlled clinical study tested copper tripeptide serum in a double-blind design, providing the gold-standard clinical evidence that followed from this laboratory foundation

AOD 9604 is a synthetic peptide derived from the C-terminus of human growth hormone

Vitamin D is given separately for best absorption and safety

You can read more about the link between mitochondrial dysfunction and neurodegenerative disease in the BMG LABTECH blog Mitochondrial dysfunction and neurodegenerative disease

The peptide typically remains stable for 30-45 days when refrigerated

Start your injection protocol at our Pembroke Pines clinic, conveniently accessible from Miramar